Cargando…

Quality of life assessment in breast cancer patients during palliative treatment in Indonesia

BACKGROUND: This study aimed to prospectively assess quality of life (QOL), QOL domains, and pain severity in advanced stage breast cancer patients during palliative oncology treatment in Indonesia. METHODS: Advanced stage breast cancer patients > 18 years (n = 160) who began palliative oncology...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayatri, D, Efremov, L, Wienke, A, Mikolajczyk, R, Kantelhardt, EJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593967/
http://dx.doi.org/10.1093/eurpub/ckac131.205
_version_ 1784815294608310272
author Gayatri, D
Efremov, L
Wienke, A
Mikolajczyk, R
Kantelhardt, EJ
author_facet Gayatri, D
Efremov, L
Wienke, A
Mikolajczyk, R
Kantelhardt, EJ
author_sort Gayatri, D
collection PubMed
description BACKGROUND: This study aimed to prospectively assess quality of life (QOL), QOL domains, and pain severity in advanced stage breast cancer patients during palliative oncology treatment in Indonesia. METHODS: Advanced stage breast cancer patients > 18 years (n = 160) who began palliative oncology treatment were enrolled in the study using convenience sampling. They completed the EORTC QLQ-C15-PAL questionnaire and pain severity (Visual Analogue Scale, VAS) score at three-time points (baseline (T0), three-(T1) and six-months (T2) follow-up). The repeated measures analysis of variance (ANOVA) model was used to assess the QOL, QOL domains, and pain severity changes over time adjusted for age, place of residence, marital status, and Karnofsky Performance Status score at baseline. We classified the change over time in three qualitative groups (deterioration, improvement, or trivial/no difference). We considered it clinically relevant if patients had a 10-point difference. RESULTS: The mean age of included patients (n = 159) was 50 years. Most lived in an urban area (72.3%), had low education (71.7%), and were married (81.8%). The repeated measures ANOVA showed that the QOL score, emotional functioning, fatigue, dyspnea, appetite loss, constipation, and VAS pain score remained stable over the 6-months period. In contrast: physical functioning declined (medium to large deterioration (-19.8 (95% CI -27.2 to -12.5)) between T0 to T2), however there was an improvement in the insomnia domain (medium improvement (-13.4 (95% CI -19.9 to -6.9)) between T0 to T2). CONCLUSIONS: Our findings indicated that advanced stage breast cancer patients adapted well to palliative oncology treatment over six months of observation. There was deterioration in physical functioning, but improvement in insomnia. However, more attention is needed from clinicians to achieve improvement in the overall QOL score and specific QOL domains. KEY MESSAGES: • Focusing on improvement overall QOL score and specific QOL domains will lead to better advanced stage breast cancer patients’ satisfaction and care. • Information is limited on palliative treatment satisfaction in low and lower middle-income countries, therefore this study has important impact on further policy considerations in Indonesia.
format Online
Article
Text
id pubmed-9593967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-95939672022-11-22 Quality of life assessment in breast cancer patients during palliative treatment in Indonesia Gayatri, D Efremov, L Wienke, A Mikolajczyk, R Kantelhardt, EJ Eur J Public Health Poster Displays BACKGROUND: This study aimed to prospectively assess quality of life (QOL), QOL domains, and pain severity in advanced stage breast cancer patients during palliative oncology treatment in Indonesia. METHODS: Advanced stage breast cancer patients > 18 years (n = 160) who began palliative oncology treatment were enrolled in the study using convenience sampling. They completed the EORTC QLQ-C15-PAL questionnaire and pain severity (Visual Analogue Scale, VAS) score at three-time points (baseline (T0), three-(T1) and six-months (T2) follow-up). The repeated measures analysis of variance (ANOVA) model was used to assess the QOL, QOL domains, and pain severity changes over time adjusted for age, place of residence, marital status, and Karnofsky Performance Status score at baseline. We classified the change over time in three qualitative groups (deterioration, improvement, or trivial/no difference). We considered it clinically relevant if patients had a 10-point difference. RESULTS: The mean age of included patients (n = 159) was 50 years. Most lived in an urban area (72.3%), had low education (71.7%), and were married (81.8%). The repeated measures ANOVA showed that the QOL score, emotional functioning, fatigue, dyspnea, appetite loss, constipation, and VAS pain score remained stable over the 6-months period. In contrast: physical functioning declined (medium to large deterioration (-19.8 (95% CI -27.2 to -12.5)) between T0 to T2), however there was an improvement in the insomnia domain (medium improvement (-13.4 (95% CI -19.9 to -6.9)) between T0 to T2). CONCLUSIONS: Our findings indicated that advanced stage breast cancer patients adapted well to palliative oncology treatment over six months of observation. There was deterioration in physical functioning, but improvement in insomnia. However, more attention is needed from clinicians to achieve improvement in the overall QOL score and specific QOL domains. KEY MESSAGES: • Focusing on improvement overall QOL score and specific QOL domains will lead to better advanced stage breast cancer patients’ satisfaction and care. • Information is limited on palliative treatment satisfaction in low and lower middle-income countries, therefore this study has important impact on further policy considerations in Indonesia. Oxford University Press 2022-10-25 /pmc/articles/PMC9593967/ http://dx.doi.org/10.1093/eurpub/ckac131.205 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Displays
Gayatri, D
Efremov, L
Wienke, A
Mikolajczyk, R
Kantelhardt, EJ
Quality of life assessment in breast cancer patients during palliative treatment in Indonesia
title Quality of life assessment in breast cancer patients during palliative treatment in Indonesia
title_full Quality of life assessment in breast cancer patients during palliative treatment in Indonesia
title_fullStr Quality of life assessment in breast cancer patients during palliative treatment in Indonesia
title_full_unstemmed Quality of life assessment in breast cancer patients during palliative treatment in Indonesia
title_short Quality of life assessment in breast cancer patients during palliative treatment in Indonesia
title_sort quality of life assessment in breast cancer patients during palliative treatment in indonesia
topic Poster Displays
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593967/
http://dx.doi.org/10.1093/eurpub/ckac131.205
work_keys_str_mv AT gayatrid qualityoflifeassessmentinbreastcancerpatientsduringpalliativetreatmentinindonesia
AT efremovl qualityoflifeassessmentinbreastcancerpatientsduringpalliativetreatmentinindonesia
AT wienkea qualityoflifeassessmentinbreastcancerpatientsduringpalliativetreatmentinindonesia
AT mikolajczykr qualityoflifeassessmentinbreastcancerpatientsduringpalliativetreatmentinindonesia
AT kantelhardtej qualityoflifeassessmentinbreastcancerpatientsduringpalliativetreatmentinindonesia